157 related articles for article (PubMed ID: 8168171)
1. The relationship between mitochondrial activation and toxicity of some substituted carboxylic acids.
Yao KW; Mao LF; Luo MJ; Schulz H
Chem Biol Interact; 1994 Mar; 90(3):225-34. PubMed ID: 8168171
[TBL] [Abstract][Full Text] [Related]
2. 4-Bromo-2-octenoic acid specifically inactivates 3-ketoacyl-CoA thiolase and thereby fatty acid oxidation in rat liver mitochondria.
Li JX; Schulz H
Biochemistry; 1988 Aug; 27(16):5995-6000. PubMed ID: 3191104
[TBL] [Abstract][Full Text] [Related]
3. 4-Bromocrotonic acid, an effective inhibitor of fatty acid oxidation and ketone body degradation in rat heart mitochondria. On the rate-determining step of beta-oxidation and ketone body degradation in heart.
Olowe Y; Schulz H
J Biol Chem; 1982 May; 257(10):5408-13. PubMed ID: 7068598
[TBL] [Abstract][Full Text] [Related]
4. 3-Mercaptopropionic acid, a potent inhibitor of fatty acid oxidation in rat heart mitochondria.
Sabbagh E; Cuebas D; Schulz H
J Biol Chem; 1985 Jun; 260(12):7337-42. PubMed ID: 3997873
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial beta-oxidation of 2-methyl fatty acids in rat liver.
Mao LF; Chu C; Luo MJ; Simon A; Abbas AS; Schulz H
Arch Biochem Biophys; 1995 Aug; 321(1):221-8. PubMed ID: 7639525
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase.
Yang SY; He XY; Schulz H
J Biol Chem; 1987 Sep; 262(27):13027-32. PubMed ID: 3654601
[TBL] [Abstract][Full Text] [Related]
7. Regulation of fatty acid beta-oxidation in rat heart mitochondria.
Wang HY; Baxter CF; Schulz H
Arch Biochem Biophys; 1991 Sep; 289(2):274-80. PubMed ID: 1898072
[TBL] [Abstract][Full Text] [Related]
8. 4-bromotiglic acid, a novel inhibitor of thiolases and a tool for assessing the cooperation between the membrane-bound and soluble beta-oxidation systems of rat liver mitochondria.
Liang X; Schulz H
Biochemistry; 1998 Nov; 37(44):15548-54. PubMed ID: 9799519
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatic fatty acid:coenzyme A ligases in the metabolism of xenobiotic carboxylic acids.
Knights KM
Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):776-82. PubMed ID: 9784915
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial metabolism of valproic acid.
Li J; Norwood DL; Mao LF; Schulz H
Biochemistry; 1991 Jan; 30(2):388-94. PubMed ID: 1988037
[TBL] [Abstract][Full Text] [Related]
11. Aspects of long-chain acyl-COA metabolism.
Tol VA
Mol Cell Biochem; 1975 Apr; 7(1):19-31. PubMed ID: 1134497
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.
Chase JF; Tubbs PK
Biochem J; 1972 Aug; 129(1):55-65. PubMed ID: 4646779
[TBL] [Abstract][Full Text] [Related]
13. The inhibition by valproic acid of the mitochondrial oxidation of monocarboxylic and omega-hydroxymonocarboxylic acids: possible implications for the metabolism of gamma-aminobutyric acid.
Draye JP; Vamecq J
J Biochem; 1987 Jul; 102(1):235-42. PubMed ID: 3117781
[TBL] [Abstract][Full Text] [Related]
14. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats.
Kibayashi M; Nagao M; Chiba S
Pediatr Int; 1999 Feb; 41(1):52-60. PubMed ID: 10200137
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects.
Ventura FV; Ruiter J; Ijlst L; de Almeida IT; Wanders RJ
Mol Genet Metab; 2005 Nov; 86(3):344-52. PubMed ID: 16176879
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions.
Ponchaut S; van Hoof F; Veitch K
Biochem Pharmacol; 1992 Jun; 43(11):2435-42. PubMed ID: 1610408
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids.
Hanley PJ; Dröse S; Brandt U; Lareau RA; Banerjee AL; Srivastava DK; Banaszak LJ; Barycki JJ; Van Veldhoven PP; Daut J
J Physiol; 2005 Jan; 562(Pt 2):307-18. PubMed ID: 15513944
[TBL] [Abstract][Full Text] [Related]
18. Studies on the effects of saturated and unsaturated short-chain monocarboxylic acids on the energy metabolism of rat liver mitochondria.
Gregersen N
Pediatr Res; 1979 Nov; 13(11):1227-30. PubMed ID: 514688
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic hypoxia on hepatic triacylglycerol concentration and mitochondrial fatty acid oxidizing capacity in liver and heart.
Kinnula VL; Hassinen I
Acta Physiol Scand; 1978 Jan; 102(1):64-73. PubMed ID: 626089
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
Thayer WS
Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
